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Abstract
Objectives Coronary heart disease (CHD) is the most
common cause of mortality and morbidity world-wide.
Evidence on ethnic differences between the Roma and non-
Roma regarding medical risk factors is scarce. The aim of
this study was to assess differences in medical risk factors
and the severity of CHD in Roma compared with non-
Roma CHD patients, adjusted for gender, age and
education.
Methods Six hundred seventy four patients were included
in this cross-sectional study (132 Roma, 542 non-Roma).
Data on medical risk factors, symptoms, medication and
severity of CHD were obtained from medical records. After
matching Roma and non-Roma according to education,
linear and logistic regression analyses with adjustments for
gender and age were used.
Results Compared with non-Roma, Roma patients had
significantly more risk factors and more severe types of
CHD. They were treated less frequently with statins and
beta-blockers, were more frequently left on pharmaco-
therapy and surgically revascularised. These differences
remained after controlling for education, gender and age.
Conclusions Roma CHD patients have a worse risk pro-
file at entry of care and seem to be undertreated compared
with non-Roma CHD patients.
Keywords Roma  Coronary heart disease 
Medical risk factors  Coronary angiography
Introduction
Coronary heart disease (CHD) ranks among cardiovascular
diseases as the most common cause of mortality and
morbidity. The publication ‘‘European Cardiovascular
Disease Statistics 2008’’ (Allender et al. 2012) showed that
CHD remains the most common cause of death in the
European Union. The Framingham Heart Study was one of
the first studies to show that medical risk factors—e.g. age,
total and high-density lipoprotein cholesterol, systolic
blood pressure, treatment for hypertension, smoking and
diabetes status—influenced the prevalence and incidence
of CHD in the general population (D’Agostino et al. 2008).
Today many health organisations, institutions and gov-
ernments are trying to target the population as a whole and
people at high risk in particular, to reduce the burden of
increasing numbers of cardiovascular deaths and morbidity
(Graham and Atar 2007).
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Ethnic minorities seem to generally have unfavourable
medical risk factors more frequently than majority popu-
lations (Baker et al. 2002; Cappuccio et al. 1997), but
studies on ethnic differences regarding this trend are rela-
tively scarce. Cappuccio et al. (1997, 2002) found higher
prevalence rates of cardiovascular risk factors in certain
ethnic groups in Britain compared with the majority pop-
ulation. The association between socio-economic status
(SES) and cardiovascular disease risk factors has also been
described in the past (Bahonar et al. 2011; Cirera et al.
2013; Hajsheikholeslami et al. 2011).
One of the largest minority groups in Central and
Eastern Europe is the Roma population. The highest con-
centration of Roma in Europe can be found in the Balkan
and the Carpathian regions. In the Slovak Republic Roma
are considered to be the second largest minority group
(Ginter et al. 2001). According to professional demo-
graphic estimates, approximately 380,000 Roma live in
Slovakia, which represents 7.2 % of the total population of
the country (Vano 2001). Previous studies have found
higher mortality and lower life expectancy for Roma than
for non-Roma (Koupilova et al. 2001; Nozdrovicky 1991).
Ginter et al. (2001) reported that premature/untimely car-
diovascular mortality occurred more than 2.5 times more
frequently among male Roma than among the average male
in the Slovak population. High prevalence rates of diabetes,
chronic infections and obesity, and very high atherogenic
indices (total/HDL cholesterol) were found in this ethnic
minority group (Ginter et al. 2001). Kolvek et al. (2012)
showed a higher risk of end stage renal disease to be
associated with Roma ethnicity, which might be partially
explained by a higher occurence of diabetic nephropathy.
Rosicova et al. (2011) found Roma ethnicity as a predictor
of regional infant mortality rate in Slovakia. This is likely
to contribute to the poorer CHD outcomes among Roma
(Ginter 1998; McKee 1997; Hajioff and McKee 2000), but
evidence on this is lacking.
Therefore, the aim of this study was to assess differ-
ences in medical risk factors for CHD and the severity of
CHD in Roma compared with non-Roma CHD patients,
adjusted for gender, age and education level.
Methods
Patients
Consecutive adult Roma and non-Roma patients undergo-
ing routine coronary angiography (CAG) in the East
Slovakian Institute for Cardiac and Vascular Diseases,
Kosice, Slovakia, in the years 2001–2010 were asked to
participate in the study. Ethnicity was measured based on
each patient’s declaration and identification by the doctor.
In the case of a mismatch the opinion of a third person (a
head-nurse) was decisive. The study was approved by the
local ethics committee, including written informed consent.
Procedures and measures
Socio-demographic data, disease history, health-related
behaviour, clinical and laboratory examination results, use of
drugs, coronary findings and type of treatment were collected
following the protocol and registered in the medical records
of each patient. Socio-demographic data concerned age and
gender. Disease history included family and personal history
of CHD, previous myocardial infarction, diabetes mellitus,
arterial hypertension and dyslipidaemia. We also asked
about smoking status (smoker or non-smoker) and alcohol
use (alcohol consumption yes or no).
Body mass index (BMI), functional status according to
the New York Heart Association (NYHA—ranging from
class I denoting mild dyspnoe to class IV denoting severe
dyspnoe) and the Canadian Cardiovascular Society (CCS—
ranging from class I, denoting mild angina, to class IV,
denoting severe angina) classes, systolic and diastolic
blood pressure levels, heart frequency and ejection fraction
from standard transthoracic echocardiography were mea-
sured during the clinical examination. Levels of total, LDL
and HDL cholesterol, triglycerides and serum creatinine
were registered according to laboratory findings.
Regarding the use of drugs, we collected data about the
use of beta-blockers, nitrates, statins and other common
cardiovascular drugs (like aspirin, clopidogrel, angiotensin-
converting enzyme inhibitors, angiotensin-1 blockers or
calcium channel antagonists).
Moreover, we obtained data on coronary findings from
CAG and on treatment modality [conservative pharmaco-
logical treatment, percutaneous coronary intervention
(PCI) or coronary artery bypass grafting (CABG)]. The
type of therapeutic intervention following the CAG was
determined by cardiologists based on the results of CAG
and clinical status, independently of participation in this
study.
The severity of the CHD was evaluated using the CCS
and NYHA classifications and by the number of diseased
coronary vessels found in the CAG.
Statistical analyses
As the first step, we assessed background and clinical
characteristics of the Roma and non-Roma patients. Dif-
ferences were statistically tested using the t test for
continuous variables and the v2-test or Fisher exact test
when appropriate for categorical variables. Values of
p \ 0.05 were considered statistically significant. In the
next step, we matched all Roma patients with all non-Roma
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patients according to their education to eliminate the
influence of the generally low socio-economic status (SES)
of Roma patients. Then logistic and linear regression
analyses, with adjustment for gender and age, were per-
formed to assess the effect of ethnicity on the above
mentioned health-related behaviour, clinical and laboratory
findings, use of drugs, disease severity and type of treat-
ment. We used two models to explain ethnic differences in
CHD patients. After matching for education to control for
socio-economic status, we tested in Model 1 the crude
effect of ethnicity on the outcome variables, and in Model
2 we tested the effect of ethnicity adjusted for gender and
age. All statistical analyses were performed using SPSS
16.0.1.
Results
Baseline characteristics of the study population are pre-
sented in Table 1 (N = 674). There were 132 Roma and
542 non-Roma patients. Roma patients were significantly
younger, less frequently women and had more frequently a
negative family and personal history of CHD, and a posi-
tive history of myocardial infarction than non-Roma
patients. The occurrence of arterial hypertension was
higher in the non-Roma group. Roma CHD patients
smoked more frequently, but drank alcohol less frequently
than the non-Roma patients. Lower values of systolic blood
pressure, higher heart frequency, lower levels of HDL
cholesterol, higher levels of triglycerides and serum cre-
atinine were measured in the group of Roma patients when
compared with the non-Roma group. In terms of the use of
drugs, Roma patients used fewer statins and more nitrates
(Table 1).
Roma patients showed more severe forms of angina
pectoris in the CCS classes: there were significantly more
of them in the CCS IV class, and they had fewer normal
CAGs when compared with non-Roma. Furthermore, sig-
nificantly more Roma patients received only
pharmacotherapy and underwent surgical revascularization
of the myocardium, and they underwent PCI with or
without stenting less frequently when compared with non-
Roma patients (Table 1).
After matching by education level (N = 462), we tested
in Model 1 the crude effect of ethnicity on the above-
mentioned outcome variables (Table 2). Significantly more
Roma patients had a negative family and personal history
of CHD and a history of previous myocardial infarction.
With regard to health-related behaviour, Roma patients
were more frequently smokers. The functional status of
Roma patients showed symptoms of CCS class IV more
frequently. They had higher levels of triglycerides and
serum creatinine. In the drug treatment, Roma patients used
fewer statins and beta-blockers, but more nitrates when
compared with the non-Roma group of patients. Roma
patients also had a higher risk of being left on pharmaco-
therapy and not undergoing PCI with or without stenting
and of being surgically revascularised (Table 2).
Model 2 shows that the introduction of age and gender
into the model as the other most common confounders did
not affect most ethnic differences in a clinically relevant
way, except for the history of dyslipidaemia, alcohol con-
sumption, systolic blood pressure and levels of HDL
cholesterol, where the significant differences among Roma
and non-Roma disappeared. The risk of having had a pre-
vious myocardial infarction and having a higher heart
frequency measured during physical examination also
remained higher in the Roma group of patients, but was
more strongly associated with male gender. Three-vessel
disease was associated with Roma ethnicity but not as
strongly as with male gender and age. Normal CAG was
associated not only with non-Roma ethnicity, but also with
female gender and younger age. Roma patients had an even
higher risk of being treated by CABG after controlling for
gender and age.
Adjustment for the period of assessment (2001–2005 vs.
2006–2010) hardly changed the size and statistical signif-
icance of differences between Roma and non-Roma, except
for the proportions of patients undergoing PCI/stenting and
three-vessel disease, which were no longer statistically
significant. Similarly, an additional adjustment for BMI
neither affected the size nor the statistical significance of
any ethnic difference; the biggest difference was 1.4 %.
Discussion
In this cross-sectional study of patients undergoing routine
CAG, we explored the differences between the medical risk
factors for CHD and the severity of CHD in the Roma
compared with non-Roma patients matched for education
and controlled for gender and age. Significant differences
were found in the medical risk profile of CHD by Roma
ethnicity. Most of these differences remained significant
even after controlling for education, gender and age. Roma
patients were younger, were more likely to have a negative
family and personal history of CHD, a positive personal
history of myocardial infarction and were more likely to
smoke than non-Roma patients. They had lower values of
systolic blood pressure, higher heart frequency, lower
levels of HDL cholesterol and higher levels of triglycer-
ides. There was also a significant difference in the use of
drugs that disadvantaged Roma patients. As far as the
severity of CHD was concerned, the study showed signif-
icant differences in the clinical symptoms (more Roma
patients in CCS IV class), the number of normal CAG
Roma coronary heart disease 411
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(fewer Roma had a normal CAG) and the treatment
modalities (Roma were more likely to be left on pharma-
cotherapy or to undergo surgical revascularization). These
results support the assumption that Roma patients come for
a CAG examination with worse health status than non-
Roma.
The higher percentage of patients with a negative
family and personal history among Roma might be
Table 1 Baseline
characteristics of the study
population by ethnicity
(N = 674). Kosice, Slovakia,
2010
NS not significant, bpm beats







* p \ 0.05, ** p \ 0.01,









for age and gender
Socio-demographic data
Age (years) 51.9 – 7.2 57.1 – 7.4 * ***
Age range (years) 28–71 24–79
Age category distribution
Up to 45 14.4 % 6 %
46–60 73.5 % 60 %
Above 60 12.1 % 34 %
Gender (male/female) 73.5/26.5 % 63.3/36.7 % * NS
Education
Low education 96 % 57.2 % *** ***
Middle education 2 % 19.7 % *** **
High education 2 % 23.1 % *** **
History of the disease
Negative family history of CHD 32.8 % 17.6 % * ***
Negative personal history of CHD 44.3 % 0.8 % * ***
Previous myocardial infarction 60.3 % 43.9 % * **
Diabetes mellitus 28.2 % 30.5 % NS NS
Arterial hypertension 61.8 % 79.9 % * **
Dyslipidaemia 59.5 % 51.5 % NS NS
Health-related behaviour
Alcohol consumption 46.4 % 66.7 % *** ***
Smoking 35.4 % 9.8 % * ***
Clinical and laboratory findings
Functional status CCS IV 9.4 % 2.2 % * **
Body mass index (kg/m2) 28.9 ± 5 29.0 ± 4.4 NS NS
Systolic blood pressure (mmHg) 130 – 22 135 – 19 * NS
Heart frequency (bpm) 73 – 10.4 70 – 10.5 * *
Total cholesterol (mmol/l) 5.29 ± 1.06 5.03 ± 1.2 NS NS
HDL cholesterol (mmol/l) 1.13 – 0.3 1.32 – 0.67 * NS
LDL cholesterol (mmol/l) 2.95 ± 0.83 3.02 ± 1.98 NS NS
Triglycerides (mmol/l) 2.48 – 1.28 2 – 1.62 * **
Serum creatinine (mmol/l) 96.7 – 26.2 90.2 – 19.4 * *
Ejection fraction (%) 49.7 ± 10 51 ± 20 NS NS
Use of drugs
Statins 45.3 % 69.1 % * ***
Nitrates 83.8 % 65.6 % * ***
Beta-blockers 75.2 % 82.8 % NS NS
Coronary findings
One-vessel disease 27.9 % 23.7 % NS NS
Two-vessel disease 27.9 % 26.3 % NS NS
Three-vessel disease 33.3 % 27.6 % NS *
Left main disease 3.0 % 5.4 % NS NS
Normal CAG 9.2 % 25.3 % *** ***
Type of treatment
Pharmacotherapy 33.8 % 22.4 % * *
PCI/stent 18.5 % 28.3 % * *
CABG 38.5 % 24 % * ***
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explained by the lower level of education in this group of
patients and thus worse knowledge regarding their own
health status and that of their relatives (Filadelfiova et al.
2007). It seems that in the Roma group lower levels of
HDL cholesterol and higher levels of triglycerides also
contribute to the worse medical risk profile of CHD
patients. This is probably caused by a higher consumption
of animal fat with saturated fatty acids and a lack of
vegetables and fruits in the diets of Roma patients
(Brazdova et al. 1998).
Regarding alcohol consumption, no significant differ-
ence was found after controlling for the above-mentioned
confounders. The symptoms of CHD measured in the CCS
classes are worse in the Roma patients: this is closely
associated with their more severe forms of CHD. Roma
also have three-vessel disease more frequently and in
contrast normal CAGs much less frequently. The relative
underuse of PCI with or without stenting might be
explained again by worse coronary findings and thus more
need for surgical revascularization. Despite the fact that
Roma patients are more likely to be left on pharmaco-
therapy, they are often not treated adequately. We found a
significant undertreatment with statins and beta-blockers.
The higher use of nitrates as purely symptomatic drugs
might be explained by the more severe symptoms in the
Roma group of patients.
Table 2 Associations of ethnicity, adjusted for educational level,
with history of the disease, health-related behaviour, clinical and
laboratory findings, use of drugs, coronary findings and type of
treatment adjusted for gender and age: odds ratios (OR) or beta
coefficients (B) with 95 % confidence intervals (95 % CI), signif-
icance of the model change (smc) (N = 462) Kosice, Slovakia, 2010




OR or B with (95 %CI)
Ethnicity adjusted for
educational level, gender
and age (Roma vs. non-Roma)
OR or B with (95 %CI)
History of the disease
Negative family history of CHD (OR) 1.85 (1.18, 2.94)** ** 2.04 (1.25, 3.33)** *
Negative personal history of CHD (OR) 83.33 (25.64, 250.00)*** *** 76.92 (22.73, 250.00)*** ***
Previous myocardial infarction (OR) 1.64 (1.09, 2.44)* * 1.56 (1.01, 2.44)* **
Arterial hypertension (OR) 0.41 (0.26, 0.64)*** *** 0.58 (0.36, 0.93)* ***
Dyslipidaemia (OR) 1.52 (1.01, 2.33)* * 1.52 (0.98, 2.33) NS
Health-related behaviour
Alcohol consumption (OR) 0.67 (0.24, 1.83) NS 0.45 (0.16, 1.29) ***
Smoking (OR) 4.76 (2.78, 7.69)*** *** 3.34 (1.98, 5.78)*** ***
Clinical and laboratory findings
Functional status CCS IV (OR) 20.00 (2.38, 100.00)** *** 34.96 (3.97, 308.13)** ***
Systolic blood pressure (B) 5.38 (0.96, 9.80)* * 2.38 (-2.20, 6.96) ***
Heart frequency (B) 23.13 (25.35, 20.91)** ** 23.33 (25.68, 20.99)** NS
HDL cholesterol (B) 0.23 (0.03, 0.43)* * 0.17 (-0.04, 0.38) *
Triglycerides (B) 20.48 (20.81, 20.15)** ** 20.42 (20.76, 20.07)* NS
Serum creatinine (B) 27.83 (212.53, 23.13)** ** 28.43 (213.21, 23.64)** ***
Use of drugs:
Statins (OR) 0.36 (0.23, 0.56)*** *** 0.38 (0.24, 0.60)*** ***
Nitrates (OR) 2.44 (1.43, 4.35)** ** 2.86 (1.61, 5.00)*** **
Beta-blockers (OR) 0.58 (0.34, 0.98)* * 0.55 (0.31, 0.96)* NS
Coronary findings:
Three-vessel disease (OR) 0.65 (0.40, 1.05) NS 0.54 (0.32, 0.91)* **
Normal CAG (OR) 0.28 (0.15, 0.54)*** *** 0.23 (0.11, 0.46)*** ***
Type of treatment:
Pharmacotherapy (OR) 1.67 (1.08, 2.63)* * 1.61 (1.01, 2.56)* NS
PCI/stent (OR) 0.59 (0.35, 0.97)* * 0.57 (0.33, 0.95)* NS
CABG (OR) 2.17 (1.39, 3.33)** ** 2.50 (1.54, 4.00)*** ***
CI confidence interval, smc significance of the model change, HDL high-density lipoprotein, LDL low-density lipoprotein, CHD coronary heart
disease, CAG coronary angiography, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting
* p \ 0.05, ** p \ 0.01, *** p \ 0.001, NS not statistically significant
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Previous findings
Results similar to those of our study appear in a study by
Nozdrovicky (1991), who reported that cardiovascular
diseases were the most common cause of death among
Roma, and that the prevalence of smoking was also higher
in this group of the population. In contrast, Filadelfiova
et al. (2007) found substantially lower rates of long-term
illness in the Roma population, which might be explained
by a different understanding of disease among the Roma
and the majority population. They also identified cardio-
vascular diseases as the most common types of long-term
illnesses among Roma. Another study, from the western
part of Slovakia (Vozarova De Courten et al. 2003),
determined higher prevalences of type 2 diabetes mellitus,
metabolic syndrome, cardiovascular disease, hypercholes-
terolemia and hypertriglyceridemia in Roma. We did not
find a significant difference in the prevalence of diabetes
mellitus, and found that hypertension, as one of the most
important risk factors for the CHD, occurred even signifi-
cantly less frequent in Roma CHD patients. The Whitehall
II prospective cohort study (Britton et al. 2004) showed
that South Asians tend to be more likely to undergo cardiac
procedures and to be on secondary prevention drugs than
white participants. In our study population, Roma patients
underwent CABG more frequently, but their medical
therapy was not optimal.
Previous studies have suggested that the worse health
status of Roma population might be associated with their
lower SES. In our study, we tried to eliminate this factor by
adjusting for education. We found that significant differ-
ences that disadvantaged the Roma ethnicity still remained.
This might be partially explained by genetic factors, but
other factors such as worse access to the health care ser-
vices, culture, housing conditions, language problems or
discrimination could play a certain role as well (Reijneveld
2010; Foets 2011; Foldes and Covaci 2012).
Strengths and weaknesses of the study
We collected data from a rather large number of Roma
patients with CHD in one major cardiac centre in Slovakia,
which is unique in this field of interest. The weakness of
our study includes its observational cross-sectional design.
Implications
Strategies adopted by European countries including Slo-
vakia to control CHD are directed mostly at majority
populations. Our study shows that Roma CHD patients
have a significantly greater risk of CHD due to their worse
medical risk profile, show significant undertreatment with
statins and beta-blockers despite having more severe forms
of CHD and are more frequently left on pharmacotherapy
and surgically revascularised when compared with non-
Roma CHD patients even after controlling for education,
gender and age. Differences in clinical symptoms and
medical treatment suggest that Roma patients should
require special attention from all health care professionals.
These findings call for better prevention strategies,
including the use of mass media information (Bonaccio
et al. 2012) and improvement of the medical treatment in
high risk Roma CHD patients.
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